John Paulson A.'s most recent trade in Bausch Health Companies Inc was a trade of 7,754 Common Shares, No Par Value done at an average price of $8.1 . Disclosure was reported to the exchange on Dec. 31, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bausch Health Companies Inc | John Paulson A. | Director | Grant, award, or other acquisition of securities at price $ 8.06 per share. | 31 Dec 2024 | 7,754 | 268,049 (0%) | 0% | 8.1 | 62,497 | Common Shares, No Par Value |
Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 8.16 per share. | 30 Sep 2024 | 7,659 | 260,295 (0%) | 0% | 8.2 | 62,497 | Common Shares, No Par Value |
Bausch + Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 19.29 per share. | 30 Sep 2024 | 1,134 | 48,874 | - | 19.3 | 21,875 | Common Shares, No Par Value |
Bausch + Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 14,696 | 47,740 | - | 0 | Common Shares, No Par Value | |
Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 6.97 per share. | 28 Jun 2024 | 8,967 | 252,636 (0%) | 0% | 7.0 | 62,500 | Common Shares, No Par Value |
Bausch + Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 14.52 per share. | 28 Jun 2024 | 1,506 | 33,044 | - | 14.5 | 21,867 | Common Shares, No Par Value |
Acadian Asset Management Inc. | John A. Paulson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,764 | 7,764 | - | - | Restricted Stock Units | |
Acadian Asset Management Inc. | John A. Paulson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 7,662 | 15,996 (0%) | 0% | 0 | Common Stock | |
Acadian Asset Management Inc. | John A. Paulson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 7,662 | 0 | - | - | Restricted Stock Units | |
Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 35,360 | 243,669 (0%) | 0% | 0 | Common Shares, No Par Value | |
Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 10.61 per share. | 29 Mar 2024 | 5,890 | 208,309 (0%) | 0% | 10.6 | 62,493 | Common Shares, No Par Value |
Bausch + Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 17.30 per share. | 29 Mar 2024 | 1,264 | 31,538 | - | 17.3 | 21,867 | Common Shares, No Par Value |
Acadian Asset Management Inc. | John A. Paulson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 8,334 | 8,334 | - | - | Restricted Stock Units | |
Acadian Asset Management Inc. | John A. Paulson | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 9.79 per share. | 24 Jun 2020 | 647,263 | 20,647,815 (24%) | 0% | 9.8 | 6,336,705 | Common Stock, par value $0.001 per share |
Acadian Asset Management Inc. | John A. Paulson | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.79 per share. | 24 Jun 2020 | 647,263 | 20,000,552 (23%) | 0% | 9.8 | 6,336,705 | Common Stock, par value $0.001 per share |